In the EVEREST trial, no prognostic difference concerning diabetes-related therapeutic strategies (i.e., diet alone, oral treatment or insulin) with regard to the risk of all-cause mortality or HF-related hospitalization was observed [20]. The gene discussed is INS; the disease is diabetes mellitus.